论文部分内容阅读
目的探讨舒喘灵雾化吸入治疗小儿重症哮喘持续发作的治疗效果。方法回顾性分析我院收治的重症哮喘持续发作患儿110例,随机分为两组,对照组55例,采用布地奈德混悬液雾化吸入,治疗组在对照组的基础上加用舒喘灵雾化吸入,比较两组疗效。结果治疗组总有效率为94.5,对照组总有效率85.5,治疗组明显高于对照组,差异有统计学意义(P<0.05)。治疗组气喘症状缓解平均(16.1±2.6)h,哮鸣音消失(43.2±3.1)h。结论舒喘灵是治疗小儿重症持续哮喘发作的有效药物,值得在临床中推广使用。
Objective To investigate the therapeutic effect of Shu Chuan Ling atomized inhalation in the treatment of persistent severe asthma in children. Methods Retrospective analysis of 110 cases of severe asthma sustained attack in our hospital were randomly divided into two groups, the control group of 55 cases, the use of budesonide suspension inhalation, the treatment group in the control group based on the addition of Shu Chuanling inhalation atomization, the two groups were compared. Results The total effective rate was 94.5 in the treatment group and 85.5 in the control group, which was significantly higher in the treatment group than in the control group (P <0.05). In the treatment group, asthma symptoms relieved on average (16.1 ± 2.6) h, and wheeze disappeared (43.2 ± 3.1) h. Conclusions Shu Chuan Ling is an effective drug for the treatment of severe persistent asthma in children and is worth popularizing in clinic.